Light PharmaLightPharma

Case Studies

Proven Results at Scale

See how we've helped the world's leading pharmaceutical companies solve complex quality and compliance challenges with measurable outcomes.

Top-10 Global PharmaQuality Excellence

Quality Excellence: Achieving Right-First-Time Manufacturing Through QbD & Investigations

A leading global pharmaceutical company was experiencing recurring batch failures and high deviation rates across multiple manufacturing sites. Previous quality improvement initiatives had yielded inconsistent results, and regulatory scrutiny was increasing.

62%
Reduction in batch failures
45%
Faster investigation cycle time
$12M
Annual cost avoidance
8
Sites transformed
Read Full Case Study
Large BiotechKnowledge Management

Knowledge & Risk Management Platform Deployment Across Global Network

A fast-growing biotech was experiencing significant knowledge loss during technology transfers from R&D to commercial manufacturing and between sites. Critical process knowledge existed only in the minds of key personnel, creating unacceptable risk.

70%
Reduction in tech transfer rework
3x
Faster knowledge retrieval
8
Sites unified on one platform
5,000+
Knowledge artifacts managed
Read Full Case Study
Top-5 Pharma ManufacturerRegulatory Readiness

Mock FDA Inspection & Compliance Risk Mitigation for Critical Site

With a major FDA inspection imminent, a top-5 pharmaceutical manufacturer engaged Light Pharma to conduct a rigorous mock inspection and develop a prioritized risk mitigation plan. The site had not been inspected in 4 years and had undergone significant changes.

0
Critical findings at FDA inspection
28
Risks identified & mitigated
12 wks
Assessment to inspection-ready
15+
Observations prevented
Read Full Case Study
Specialty PharmaInvestigations

Root Cause Investigation: Resolving Chronic OOS Results with Multivariate Analysis

A specialty pharmaceutical company struggled to identify the root cause behind a persistent series of out-of-specification (OOS) batch results. Previous internal investigations had failed to substantiate a root cause, putting product supply at risk.

100%
Root cause substantiated
5
Products protected from similar risk
$4.2M
In avoided batch rejections
6 wks
Investigation closed
Read Full Case Study
Global Pharma ManufacturerQuality Excellence

Analytical Method Lifecycle Management: Ppk Improvement from 0.8 to 1.4

A pharmaceutical company identified analytical methods with significant variation relative to specifications (Ppk = 0.8) that had not yet caused out-of-specification results but posed growing risk of future OOS events and regulatory citations.

0.8
Ppk before
1.4
Ppk after
100%
OOS events prevented
Multi-site
Expanded to
Read Full Case Study

Ready to Achieve Similar Results?

Whether you need help with an upcoming inspection, complex investigation, or long-term quality strategy — let's talk about how we can help.